Responsive mesoporous silica nanocarriers in glioma therapy: A step forward in overcoming biological barriers

doi:10.5306/wjco.v16.i9.108731

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 9

This Article

(55)

(82)

(0)

(1174)

(7)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Clin Oncol. Sep 24, 2025; 16(9): 108731
Published online Sep 24, 2025. doi: 10.5306/wjco.v16.i9.108731

Full Size Figure Download Figure

Figure 3 Schematic of the internal and external triggers for stimuli-responsive mesoporous silica nanoparticle. This figure was created by BioRender.com (Supplementary material).

Citation: Abdel-Maksoud YT, Abdelhaseb AH, Abdo AAE, Kamel AM, Elsebay MT, Attia MS. Responsive mesoporous silica nanocarriers in glioma therapy: A step forward in overcoming biological barriers. World J Clin Oncol 2025; 16(9): 108731
URL: https://www.wjgnet.com/2218-4333/full/v16/i9/108731.htm
DOI: https://dx.doi.org/10.5306/wjco.v16.i9.108731

Abdel-Maksoud YT, Abdelhaseb AH, Abdo AAE, Kamel AM, Elsebay MT, Attia MS. Responsive mesoporous silica nanocarriers in glioma therapy: A step forward in overcoming biological barriers. World J Clin Oncol 2025; 16(9): 108731 [PMID: 41024832 DOI: 10.5306/wjco.v16.i9.108731]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.